NextPlat (NXPL) Revenue (2015 - 2026)
NextPlat's (NXPL) quarterly Revenue came in at $11.9 million in Q2 2026, down 10.26% year-over-year from $13.2 million in Q2 2025, and up 20.56% quarter-over-quarter from $9.9 million in Q1 2026.
Analysis
NextPlat (NXPL) Revenue (2015 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Revenue for 12 consecutive years, with $11.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Revenue fell 10.26% year-over-year to $11.9 million in Q2 2026; TTM through Jun 2026 was $48.3 million, a 17.82% decrease from a year earlier, with the FY2025 full-year figure at $54.3 million, down 17.8% from the prior year.
- Revenue was $11.9 million for Q2 2026 at NextPlat, up from $9.9 million in the prior quarter.
- Over five years, Revenue peaked at $17.5 million in Q1 2024 and troughed at $2.6 million in Q4 2022.
- A 5-year average of $10.6 million and a median of $13.0 million in 2025 frame the typical range for Revenue.
- Across the five-year window, Revenue surged 532.45% in 2023 and dropped 29.23% in 2026, its largest moves.
- Over 5 years, Revenue stood at $2.6 million in 2022, then surged by 532.45% to $16.6 million in 2023, then fell by 2.4% to $16.2 million in 2024, then decreased by 21.12% to $12.8 million in 2025, then retreated by 7.22% to $11.9 million in 2026.
- The last three Revenue figures came in at $11.9 million (Q2 2026), $9.9 million (Q1 2026), and $12.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 4.14 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 3.76 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 852.47 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 796.20 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 2.85 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 266.04 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 54.76 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 183.90 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 17.87 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 11.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.88 Mn |
| Mar 31, 2026 | 9.86 Mn |
| Dec 31, 2025 | 12.81 Mn |
| Sep 30, 2025 | 13.75 Mn |
| Jun 30, 2025 | 13.24 Mn |
| Mar 31, 2025 | 13.93 Mn |
| Dec 31, 2024 | 16.23 Mn |
| Sep 30, 2024 | 15.37 Mn |
| Jun 30, 2024 | 16.99 Mn |
| Mar 31, 2024 | 17.49 Mn |
| Dec 31, 2023 | 16.63 Mn |
| Sep 30, 2023 | 15.29 Mn |
| Jun 30, 2023 | 2.96 Mn |
| Mar 31, 2023 | 2.88 Mn |
| Dec 31, 2022 | 2.63 Mn |
| Sep 30, 2022 | 2.63 Mn |
| Jun 30, 2022 | 2.87 Mn |
| Mar 31, 2022 | 3.58 Mn |
| Dec 31, 2021 | 2.07 Mn |
| Sep 30, 2021 | 2.25 Mn |